로딩 중…
지수 로딩 중…
피플바이오
304840· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩955+0.10%
2026-06-19
Price Chart
피플바이오-62.40%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 23.23B KRW |
| Revenue | 2.71B KRW |
| Net Income | -16.94B KRW |
| Total Assets | 47.45B KRW |
| Net Assets | 29.77B KRW |
| Employees | 60 |
| Value | |
| P/B | 0.78x |
| P/S | 8.56x |
| Profitability | |
| ROE | -56.91% |
| ROA | -35.70% |
| Op. Margin | -267.76% |
| Revenue Growth | -17.48% |
| Financial Health | |
| Debt Ratio | 159.40% |
| Total Debt | 12.84B KRW |
| Cash | 2.99B KRW |
| Current Ratio | 0.46x |
| Performance | |
| 1Y Return | -62.40% |
| 1M Return | -12.47% |
| From 52W High | -67.85% |
| 1Y MDD | -77.29% |
| Trading | |
| Volume | 41,786 shares |
| Foreign Own. | 0.95% |
| Per Share | |
| EPS | -679 KRW |
| BPS | 1,240 KRW |
Company Info
PeopleBio, established in 2002, develops and manufactures blood diagnostic products for conformational protein diseases, and was listed on KOSDAQ in 2020. It specializes in early diagnosis blood test products for Alzheimer's disease, offering simple ELISA-based tests at around 100,000 won, based on SI-MDS technology for measuring oligomeric proteins. The company is expanding its technology through natural product-based Alzheimer's disease treatment development via its subsidiary Pharmacobio and Parkinson's disease diagnosis digital biomarker development with J.US. PeopleBio is headquartered in Seongnam-si, Gyeonggi-do.